key: cord-0786609-nk0qqofq
authors: Osterrieder, Nikolaus; Bertzbach, Luca D.; Dietert, Kristina; Abdelgawad, Azza; Vladimirova, Daria; Kunec, Dusan; Hoffmann, Donata; Beer, Martin; Gruber, Achim D.; Trimpert, Jakob
title: Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters
date: 2020-06-10
journal: bioRxiv
DOI: 10.1101/2020.06.10.144188
sha: 72755d34235cc3874a72b4226423c5ddb111c083
doc_id: 786609
cord_uid: nk0qqofq

In late 2019, an outbreak of a severe respiratory disease caused by an emerging coronavirus, SARS-CoV-2, resulted in high morbidity and mortality in infected humans1. Complete understanding of COVID-19, the multi-faceted disease caused by SARS-CoV-2, requires suitable small animal models, as does the development and evaluation of vaccines and antivirals2. Because age-dependent differences of COVID-19 were identified in humans3, we compared the course of SARS-CoV-2 infection in young and aged Syrian hamsters. We show that virus replication in the upper and lower respiratory tract was independent of the age of the animals. However, older hamsters exhibited more pronounced and consistent weight loss. In situ hybridization in the lungs identified viral RNA in bronchial epithelium, alveolar epithelial cells type I and II, and macrophages. Histopathology revealed clear age-dependent differences, with young hamsters launching earlier and stronger immune cell influx than aged hamsters. The latter developed conspicuous alveolar and perivascular edema, indicating vascular leakage. In contrast, we observed rapid lung recovery at day 14 after infection only in young hamsters. We propose that comparative assessment in young versus aged hamsters of SARS-CoV-2 vaccines and treatments may yield valuable information as this small-animal model appears to mirror age-dependent differences in human patients.

In late 2019, an outbreak of a severe respiratory disease caused by an emerging 23 coronavirus, SARS-CoV-2, resulted in high morbidity and mortality in infected humans 1 .

Complete understanding of COVID-19, the multi-faceted disease caused by SARS-CoV-25 2, requires suitable small animal models, as does the development and evaluation of 26 vaccines and antivirals 2 . Because age-dependent differences of COVID-19 were identified 27 in humans 3 , we compared the course of SARS-CoV-2 infection in young and aged Syrian 28 hamsters. We show that virus replication in the upper and lower respiratory tract was 29 independent of the age of the animals. However, older hamsters exhibited more 30 pronounced and consistent weight loss. In situ hybridization in the lungs identified viral 31 RNA in bronchial epithelium, alveolar epithelial cells type I and II, and macrophages.

Histopathology revealed clear age-dependent differences, with young hamsters launching 33 earlier and stronger immune cell influx than aged hamsters. The latter developed 34 conspicuous alveolar and perivascular edema, indicating vascular leakage. In contrast,

we observed rapid lung recovery at day 14 after infection only in young hamsters. We

propose that comparative assessment in young versus aged hamsters of SARS-CoV-2 37 vaccines and treatments may yield valuable information as this small-animal model 38 appears to mirror age-dependent differences in human patients. 

First, we observed age-dependent SARS-CoV-2-induced body weight losses, with more 102 pronounced weight reductions in aged compared to young hamsters (Fig. 1A-C) . Mean 103 body weight losses peaked at 6 to 7 days post-infection (dpi), with partial recovery until 14 104 dpi in both infected groups. There were no differences in body temperatures between the 105 infected groups or between infected and mock-infected animals (Fig. 1D ).

Next, we determined viral titers and SARS-CoV-2 RNA copy numbers in various tissues 107 by RT-qPCR 27,28 , and performed virus titrations from lung homogenates using Vero E6 108 cells (Fig. 1E-H) . Results were similar between age groups and confirmed high viral loads 109 in respiratory samples at early time points after infection, but relatively rapid clearance of 110 infection. It seems important to note that RT-qPCR of blood samples revealed viremia in 111 two male individuals from both age groups with viral RNA copy numbers of >10 5 at 5 and 112 7 dpi, respectively (Fig. 1I ). In these individuals, we also detected relatively high levels of 113 viral RNA in the spleen, kidneys and duodenum indicating systemic spread of SARS-CoV-114 2 in some cases (Table S1 ). To further investigate potential dissemination of infection, we 115 tested the aforementioned organs from all animals sacrificed at 5 dpi and found them to 116 be either negative for SARS-CoV-2 RNA or to contain only low levels of viral RNA (Tab. 117 S1).

Viral loads in bucco-laryngeal swabs and nasal washes appeared to be a reliable 119 surrogate of viral loads in the lungs in both age groups, as the average loads ranged 120 between 10 4 and 10 7 copies, respectively, at early times after infection, indicating that 121 these sampling techniques can be used to monitor SARS-CoV-2 replication in Syrian 122 hamsters (Fig. 1G-H) .

At 14 dpi, hamsters had mounted a robust humoral immune response as evidenced by 124 relatively high titers of neutralizing antibodies. It is worth noting that antibody titers were 125 higher in young when compared to aged hamsters (Table S1 ).

Histopathology revealed clear age-dependent differences, with young hamsters launching 127 an earlier and stronger immune cell influx into the lungs associated with a faster recovery 128 than their aged counterparts ( Fig. 2A-E) . At 2 dpi, young hamsters developed a marked 129 necro-suppurative bronchointerstitial pneumonia with strong alveolar and interstitial influx 130 of neutrophils and macrophages as well as perivascular lymphocytic cuffing, which was 131 much milder or absent in the aged group (Fig. S1A, right panel) . In contrast, only aged 132 animals developed pronounced alveolar and perivascular edema indicating vascular 133 leakage at 3 dpi (Fig. S2C) . A more diffuse, severe bronchointerstitial pneumonia was 134 similarly present in both groups at 5 dpi with onset of tissue regeneration, including 135 hyperplasia of bronchial epithelium (Fig. S1C, arrowhead) 

CoV-2 infection 29 . At 7 dpi, recovery as indicated by marked hyperplasia of bronchial 142 epithelial cells and type II alveolar epithelial cells were seen in both groups (Fig. S2A ).

Interestingly, lung tissues had almost recovered in young hamsters at day 14, while the 144 aged animals still had persistent tissue damage and active inflammation (Fig. S2B ).

From 2 dpi onwards, SARS-CoV-2 RNA was detected by in situ hybridization in bronchial 146 epithelial cells, debris in the bronchial lumen, alveolar epithelial cells type I and type II as 147 well as macrophages in both groups, again with clear age-dependent differences over 

In summary, our study examined the suitability of a small animal model to study SARS- 

This research was supported by COVID-19 grants from Freie 202

Alliance to NO as well as Deutsche 203 Forschungsgemeinschaft grant SFB-TR84 awarded to ADG

Coronavirus Infections-More Than 217 Just the Common Cold

A strategic approach to 219 COVID-19 vaccine R&D

Disparities in Age-Specific Morbidity and Mortality 222 from SARS-CoV-2 in China and the Republic of Korea

Association between age and clinical characteristics and outcomes 225 of COVID-19

SARS and MERS: 227 recent insights into emerging coronaviruses

A Genomic Perspective on the Origin and 230 Emergence of SARS-CoV-2

SARS-CoV-2 and COVID-19 in older adults: what we 233 may expect regarding pathogenesis, immune responses, and outcomes

Receptor Recognition by the 236 Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural 237 Studies of SARS Coronavirus

ACE2-Variants 239

Indicate Potential SARS-CoV-2-Susceptibility in Animals: An Extensive 240

The search for a COVID-19 animal model

Respiratory disease in rhesus macaques inoculated with 244 SARS-CoV-2

Comparative pathogenesis of COVID-19, MERS, and SARS in a 246 nonhuman primate model

Ocular conjunctival inoculation of SARS-CoV-2 can cause mild 249 COVID-19 in 2 Rhesus macaque. bioRxiv

Age-related rhesus macaque models of COVID-19

A mouse-adapted SARS-CoV-2 model for the evaluation of 254 COVID-19 medical countermeasures. bioRxiv

Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse 257 model for vaccine efficacy. bioRxiv

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

The battle against SARS and MERS coronaviruses: 261 Reservoirs and Animal Models

Animal models for SARS and MERS 264 coronaviruses

Susceptibility of ferrets, cats, dogs, and other domesticated animals to 267 SARS-coronavirus 2

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Is there an ideal animal model for SARS?

Severe acute respiratory syndrome coronavirus infection of 273 golden Syrian hamsters

Pathogenesis and transmission of SARS-CoV-2 in golden 276 hamsters

Simulation of the clinical and pathological manifestations of 278

COVID-19) in golden Syrian hamster model: 279 implications for disease pathogenesis and transmissibility

Virological assessment of hospitalized patients with COVID-282 2019

Detection of 2019 novel coronavirus (2019-nCoV) by real-284 time RT-PCR

Validation 287 of assays to monitor immune responses in the Syrian golden hamster 288 (Mesocricetus auratus)

Pulmonary Vascular Endothelialitis, Thrombosis, and 291 Angiogenesis in Covid-19

Tropism, replication competence, and innate immune 293 responses of the coronavirus SARS-CoV-2 in human respiratory tract and 294 conjunctiva: an analysis in ex-vivo and in-vitro cultures

The authors acknowledge the excellent technical assistance by Ann Reum, Annett 200 Neubert, and Simon Dökel. We would like to thank Carfil Inc. for their generous support of